A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Clinical trial NCT05536141 · RECRUITING

Trial details

NCT number: NCT05536141
Sponsor: Arcus Biosciences, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma Solid Tumors

Start date: 2022-10-26
Primary completion: 2029-03-01
Enrollment: 362

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.